Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Easiphen liquid
0913205N0AAABAB
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic Mevalia PKU Motion 20 liquid sugar free
0913205N0AAAGAG
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic PKU Air20 liquid
0913205N0AAAEAE
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic PKU cooler20 liquid
0913205N0AAAFAF
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic PKU Lophlex LQ 20 liquid
0913205N0AAAAAA
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic PKU Lophlex Select 20 liquid
0913205N0AAAHAH
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic PKU Lophlex Sensation 20
0913205N0AAACAC
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
|
Generic XPhe jump 20 liquid
0913205N0AAADAD
|
Ready to serve 20g protein equivalent (0913205) | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.